Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway

• Autori principali: Xiaoliang Hu (Autore), Cheng Li (Autore), Qian Wang (Autore), Zhixing Wei (Autore), Taizhong Chen (Autore), Yuepeng Wang (Autore), Yigang Li (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Doxorubicin (DOX) is limited in clinical application because of its cardiotoxicity. Oxidative stress and apoptosis are crucial in DOX-induced cardiac injury. Dimethyl fumarate (DMF) is an FDA-approved oral drug with powerful effects to reduce oxidative stress and apoptosis through the Nrf2 pathway....